Correlates and prevalence of menthol cigarette use among adults with serious mental illness

Nicotine and Tobacco Research

Volumn 17, Issue 3, 2015, Pages 285-291

  Young Wolff, Kelly C ^a   Hickman, Norval J ^b   Kim, Romina ^c   Gali, Kathleen ^d   Prochaska, Judith J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of California Office of the President   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; MENTHOL CIGARETTE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING; SOCIAL ASPECT; TOBACCO; UNITED STATES; CALIFORNIA; CLINICAL TRIAL; ETHNOLOGY; MIDDLE AGED; MINORITY GROUP; MULTICENTER STUDY; PSYCHOLOGY; SMOKING CESSATION; YOUNG ADULT;

MENTHOL;

ADULT; CALIFORNIA; FEMALE; HUMANS; MALE; MENTHOL; MIDDLE AGED; MINORITY GROUPS; PREVALENCE; SAN FRANCISCO; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 84945192588     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu141     Document Type: Article

References (48)

1. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Genl Psychiatry. 2004;61:1107-1115.
2. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. J Am Med Assoc. 2000;284:2606-2610.
3. Manderscheid RW, Druss B, Freeman E. Data to manage the mortality crisis. Int J Ment Health. 2008;37:49-68.
4. Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297-314.
5. Tobacco Products Scientific Advisory Committee to the Food and Drug Administration. Menthol Cigarettes and Public Health: Review of the Scientific Evidence and Recommendations. Washington, DC; 2011. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM269697.pdf. Accessed May 2012.
6. Gardiner PS. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res. 2004;6:S55-S65.
7. Glanz K, Sutton NM, Jacob Arriola KR. Operation storefront Hawaii: tobacco advertising and promotion in Hawaii stores. J Health Commun. 2006;11:699-707.
8. Yerger VB, Przewoznik J, Malone RE. Racialized geography, corporate activity, and health disparities: tobacco industry targeting of inner cities. J Health Care Poor Uuderserved. 2007;18(4 Suppl):10-38.
9. Henriksen L, Schleicher NC, Dauphinee AL, Fortmann SP. Targeted advertising, promotion, and price for menthol cigarettes in California high school neighborhoods. Nicotine Tob Res. 2011;14:116-121.
10. Caraballo RS, Asman K. Epidemiology of menthol cigarette use in the United States. Tob Induc Dis. 2011;9:S1.
11. Fernander A, Rayens MK, Zhang M, Adkins S. Are age of smoking initiation and purchasing patterns associated with menthol smoking? Addiction. 2010;105:39-45.
12. Rock VJ, Davis SP, Thorne SL, Asman KJ, Caraballo RS. Menthol cigarette use among racial and ethnic groups in the United States, 2004-2008. Nicotine Tob Res. 2010;12:S117-S124.
13. Substance Abuse and Mental Health Services Administration. The NSDUH Report: Use of Menthol Cigarettes. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. http://oas.samhsa.gov/2k9/134/134MentholCigarettes.htm. Accessed May 2012.
14. Webb-Hooper M, Zhao W, Byrne MM, et al. Menthol cigarette smoking and health, Florida 2007 BRFSS. Am J Health Behav. 2011;35:3-14.
15. US Food and Drug Administration. Preliminary Scientific Evaluation of the Possible Public Health Effects of Menthol Versus Nonmenthol Cigarettes. 2013. http://www.fda.gov/tobaccoproducts/publichealthscienceresearch/menthol/default.htm. Accessed March, 2014.
16. House Report No. 1256. 111th Congress. 1st Session. Family Smoking Prevention and Tobacco Control Act. 2008. http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/html/PLAW-111publ31.htm. Accessed March 2014.
17. Hickman NJ, Delucchi KL, Prochaska JJ. Menthol use among smokers with psychological distress: findings from the 2008 and 2009 national survey on drug use and health. Tob Control. 2012;23:7-13.
18. Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007;9:873-881.
19. Prochaska JJ, Hall S, Delucchi KL, Hall SM. Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health. In press.
20. Prochaska JJ, Hall SE, Hall SM. Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatr Serv. 2009;60:848.
21. Smith SS, Fiore MC, Baker TB. Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction. In press.
22. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addict. 1991;86:1119-1127.
23. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psych. 1983;51:390-395.
24. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat. 1998;59:22-33.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Publication; 1994.
26. Eisen SV, Normand SL, Belanger AJ, Spiro A III, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care. 2004;42:1230-1241.
27. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
28. Substance Abuse and Mental Health Services Administration. 2009 National Survey on Drug Use and Health. Rockville, MD; 2010. http://www.icpsr.umich.edu/files/SAMHDA/survey-inst/29621-0001-Questionnaire-specifications.pdf. Accessed May 2012.
29. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-45, HHS Publication No. (SMA) 12-4725. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
30. SAS Institute Inc. SAS/STAT 9.3 User's Guide. Cary, NC: SAS Institute Inc; 2011.
31. Anderson SJ. Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents. Tob Control. 2011;20:ii20-ii28.
32. Kreslake JM, Wayne GF, Connolly GN. The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res. 2008;10:705-715.
33. Strand JE, Nyback H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur Psychiat. 2005;20:50-54.
34. Benowitz NL, Herrera B, Jacob P. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004;310:1208-1215.
35. Brody AL, Mukhin AG, La Charite J, et al. Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. Int J Neuropsychoph. 2012;1:1-10.
36. Lindemann J, Tsakiropoulou E, Scheithauer MO. Impact of menthol inhalation on nasal mucosal temperature and nasal patency. Am J Rhinol. 2008;22:402-405.
37. Wayne GF, Connolly GN. Application, function, and effects of menthol in cigarettes: a survey of tobacco industry documents. Nicotine Tob Res. 2004;6:S43-S54.
38. Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophr Bull. 2008;34:555-567.
39. Hyland A, Bauer JE, Li Q, et al. Higher cigarette prices influence cigarette purchase patterns. Tob Control. 2005;14:86-92.
40. Weeks MO. Tobacco and media exposure in poor neighbourhoods: implications for the incidence of smoking among community residents. Int J Nurs Pract. 2011;17:534-538.
41. Schleicher N, Johnson TO, Dauphinee AL, Henriksen L. Tobacco Marketing in California's Retail Environment (2008-2011), Final report for the California Tobacco Advertising Survey (2011). Stanford, CA: Stanford Prevention Research Center; 2013.
42. Dauphinee AL, Doxey JR, Schleicher NC, Fortmann SP, Henriksen L. Racial differences in cigarette brand recognition and impact on youth smoking. BMJ Public Health. 2013;13:170.
43. Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. Aust NZJ Psychiatry. 2005;39:866-885.
44. Winickoff J, McMillen R, Vallone D, et al. US attitudes about banning menthol in cigarettes: results from a nationally representative survey. Am J Public Health. 2011;101:1234-1236.
45. Pearson JL, Abrams DB, Niaura RS, Richardson A, Vallone DM. A ban on menthol cigarettes: impact on public opinion and smokers' intention to quit. Am J Public Health. 2012;102:e107-e114.
46. Wackowski OA, Manderski MT, Delnevo CD. Young adults' behavioral intentions surrounding a potential menthol cigarette ban. Nicotine Tob Res. 2014;16:876-880.
47. Levy DT, Pearson JL, Villanti AC, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011;101:1236-1240.
48. Bolcic-Jankovic D, Biener L. Public opinion about FDA regulation of menthol and nicotine. Tob Control. In press.